Abstract
Renal masses are diagnosed with an increasing incidence recently, especially as an incidental finding, due to the high frequency of imaging investigations being performed. Options of management for those situations are multiple, ranging from active surveillance (AS), ablation techniques, to partial or radical nephrectomies. Currently, most renal masses are managed based on imaging evaluation only. There are many shortcomings to this approach, due to limitations of radiologic techniques. This is especially true on specific masses where it can be difficult to differentiate benign from malignant features. Percutaneous renal mass biopsies (RMBs) may be of extreme value and can produce a tremendous impact on management of renal masses, providing a more accurate diagnosis and guiding management discussion with patients, as well as potentially avoiding unnecessary procedures and their associated morbidity. Contrary to initial studies and misconceptions, RMB has shown to have low morbidity, minimal risks, and excellent accuracy. The indications for RMB are increasing, and this approach may become the standard of care in the near future.
Memoriam
It is with great sadness that we were recently notified of the passing of Dr. Vladimir Mouraviev. Vlad, as we have come to know him, was a tireless academic scholar who was dedicated to advancing the field of genitourinary oncology. He made significant scientific contributions most notably in the area of prostate cancer and in the evolving role of focal therapy. This is where Vlad and I (Phil) began our collaborations as part of the prostate cancer cryotherapy on-line data (COLD) registry resulting in several high-quality peer-reviewed publications led by Dr. Mouraviev. Vlad will be greatly missed by all of us, and our field has lost one of its bright stars who was fully committed to the unrelenting search of optimizing the treatment outcomes of our patients. We thank him for his invaluable contributions and close friendship.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Robson CJ. Radical nephrectomy for renal cell carcinoma. J Urol. 1963;89:37–42.
Porter MP, Lin DW. Trends in renal cancer surgery and patient provider characteristics associated with partial nephrectomy in the United States. Urol Oncol. 2007;25(4):298–302.
Highlights in kidney cancer from the 2017 American Society of Clinical Oncology Annual Meeting. Clin Adv Hematol Oncol. 2017;15(9):682–3.
Mastoraki A, Mastoraki S, Tsikala-Vafea M, Papanikolaou IS, Lazaris A, Smyrniotis V, Arkadopoulos N. Prognostic benefit of surgical management of renal cell carcinoma invading the inferior vena cava. Indian J Surg Oncol. 2017;8(1):14–8.
Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98(18):1331–4.
Kang SK, Scherer LD, Megibow AJ, Higuita LJ, Kim N, Braithwaite RS, Fagerlin A. A randomized study of patient risk perception for incidental renal findings on diagnostic imaging tests. AJR Am J Roentgenol. 2018;210(2):369–75.
Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Leibovich BC, Zincke H. A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma. J Urol. 2003;170(6 Pt 1):2225–32.
Beland MD, Mayo-Smith WW, Dupuy DE, Cronan JJ, DeLellis RA. Diagnostic yield of 58 consecutive imaging-guided biopsies of solid renal masses: should we biopsy all that are indeterminate? AJR Am J Roentgenol. 2007;188(3):792–7.
Thompson RH, Hill JR, Babayev Y, Cronin A, Kaag M, Kundu S, et al. Metastatic renal cell carcinoma risk according to tumor size. J Urol. 2009;182(1):41–5.
Campbell S, Uzzo RG, Allaf ME, Bass EB, Cadeddu JA, Chang A, et al. Renal mass and localized renal cancer: AUA guideline. J Urol. 2017;198(3):520–9.
Breau RH, Crispen PL, Jenkins SM, Blute ML, Leibovich BC. Treatment of patients with small renal masses: a survey of the American Urological Association. J Urol. 2011;185(2):407–13.
Leveridge MJ, Finelli A, Kachura JR, Evans A, Chung H, Shiff DA, et al. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol. 2011;60(3):578–84.
Dyer RB, Chen MY, Zagoria RJ. Intravenous urography: technique and interpretation. Radiographics. 2001;21(4):799–821; discussion 822–4.
Bosniak MA. The current radiological approach to renal cysts. Radiology. 1986;158(1):1–10.
Gulati M, King KG, Gill IS, Pham V, Grant E, Duddalwar VA. Contrast-enhanced ultrasound (CEUS) of cystic and solid renal lesions: a review. Abdom Imaging. 2015;40(6):1982–96.
Nicolau C, et al. Prospective evaluation of CT indeterminate renal masses using US and contrast-enhanced ultrasound. Abdom Imaging. 2015;40:542–51.
Park BK, Kim B, Kim SH, Ko K, Lee HM, Choi HY. Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US. Eur J Radiol. 2007;61(2):310–4.
Wang C, Yu C, Yang F, Yang G. Diagnostic accuracy of contrast-enhanced ultrasound for renal cell carcinoma: a meta-analysis. Tumour Biol. 2014;35(7):6343–50.
Wu Y, Du L, Li F, Zhang H, Cai Y, Jia X. Renal oncocytoma: contrast-enhanced sonographic features. J Ultrasound Med. 2013;32(3):441–8.
Kang SK, Chandarana H. Contemporary imaging of the renal mass. Urol Clin North Am. 2012;39(2):161–70, vi.
Berland LL, Silverman SG, Gore RM, Mayo-Smith WW, Megibow AJ, Yee J, et al. Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol. 2010;7(10):754–73.
Pierorazio PM, Hyams ES, Tsai S, Feng Z, Trock BJ, Mullins JK, et al. Multiphasic enhancement patterns of small renal masses (</=4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma. Urology. 2013;81(6):1265–71.
Kopp RP, Aganovic L, Palazzi KL, Cassidy FH, Sakamoto K, Derweesh IH. Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula. Can J Urol. 2013;20(3):6790–7.
Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Raman SS. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology. 2013;267(2):444–53.
Egbert ND, Caoili EM, Cohan RH, Davenport MS, Francis IR, Kunju LP, Ellis JH. Differentiation of papillary renal cell carcinoma subtypes on CT and MRI. AJR Am J Roentgenol. 2013;201(2):347–55.
Bird VG, Kanagarajah P, Morillo G, Caruso DJ, Ayyathurai R, Leveillee R, Jorda M. Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography. World J Urol. 2011;29(6):787–92.
Millet I, Doyon FC, Hoa D, Thuret R, Merigeaud S, Serre I, Taourel P. Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT? AJR Am J Roentgenol. 2011;197(4):887–96.
Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma. J Urol. 2002;168(4 Pt 1):1315–25.
Richmond L, Atri M, Sherman C, Sharir S. Renal cell carcinoma containing macroscopic fat on CT mimics an angiomyolipoma due to bone metaplasia without macroscopic calcification. Br J Radiol. 2010;83(992):e179–81.
Agarwal R, Brunelli SM, Williams K, Mitchell MD, Feldman HI, Umscheid CA. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis. Nephrol Dial Transplant. 2009;24(3):856–63.
Allen BC, Tirman P, Jennings Clingan M, Manny J, Del Gaizo AJ, Leyendecker JR. Characterizing solid renal neoplasms with MRI in adults. Abdom Imaging. 2014;39(2):358–87.
Tanaka H, Yoshida S, Fujii Y, Ishii C, Tanaka H, Koga F, et al. Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma. Int J Urol. 2011;18(10):727–30.
McGahan JP, Lamba R, Fisher J, Starshak P, Ramsamooj R, Fitzgerald E, Yen P. Is segmental enhancement inversion on enhanced biphasic MDCT a reliable sign for the noninvasive diagnosis of renal oncocytomas? AJR Am J Roentgenol. 2011;197(4):W674–9.
Yoshimitsu K, Kakihara D, Irie H, Tajima T, Nishie A, Asayama Y, et al. Papillary renal carcinoma: diagnostic approach by chemical shift gradient-echo and echo-planar MR imaging. J Magn Reson Imaging. 2006;23(3):339–44.
Gurel S, Narra V, Elsayes KM, Siegel CL, Chen ZE, Brown JJ. Subtypes of renal cell carcinoma: MRI and pathological features. Diagn Interv Radiol. 2013;19(4):304–11.
Thompson RH, Kurta JM, Kaag M, Tickoo SK, Kundu S, Katz D, et al. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol. 2009;181(5):2033–6.
Tsivian M, Mouraviev V, Albala DM, Caso JR, Robertson CN, Madden JF, Polascik TJ. Clinical predictors of renal mass pathological features. BJU Int. 2011;107(5):735–40.
Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170(6 Pt 1):2217–20.
Gill IS, Matin SF, Desai MM, Kaouk JH, Steinberg A, Mascha E, et al. Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. J Urol. 2003;170(1):64–8.
Neuzillet Y, Lechevallier E, Andre M, Daniel L, Coulange C. Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol. 2004;171(5):1802–5.
Volpe A, Mattar K, Finelli A, Kachura JR, Evans AJ, Geddie WR, et al. Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J Urol. 2008;180(6):2333–7.
Kim JK, Park SY, Shon JH, Cho KS. Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. Radiology. 2004;230(3):677–84.
Farrell C, Noyes SL, Tourojman M, Lane BR. Renal angiomyolipoma: preoperative identification of atypical fat-poor AML. Curr Urol Rep. 2015;16(3):12.
Rothman J, Egleston B, Wong YN, Iffrig K, Lebovitch S, Uzzo RG. Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis. J Urol. 2009;181(1):29–33.
Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis. Cancer. 2007;109(9):1763–8.
Lane BR, Abouassaly R, Gao T, Weight CJ, Hernandez AV, Larson BT, et al. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older. Cancer. 2010;116(13):3119–26.
Kunkle DA, Crispen PL, Chen DY, Greenberg RE, Uzzo RG. Enhancing renal masses with zero net growth during active surveillance. J Urol. 2007;177(3):849–53; discussion 853–4.
Remzi M, Ozsoy M, Klingler HC, Susani M, Waldert M, Seitz C, et al. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol. 2006;176(3):896–9.
Kyle CC, Wingo MS, Carey RI, Leveillee RJ, Bird VG. Diagnostic yield of renal biopsy immediately prior to laparoscopic radiofrequency ablation: a multicenter study. J Endourol. 2008;22(10):2291–3.
Beemster P, Phoa S, Wijkstra H, de la Rosette J, Laguna P. Follow-up of renal masses after cryosurgery using computed tomography; enhancement patterns and cryolesion size. BJU Int. 2008;101(10):1237–42.
Weight CJ, Kaouk JH, Hegarty NJ, Remer EM, O’Malley CM, Lane BR, et al. Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors. J Urol. 2008;179(4):1277–81; discussion 1281–3.
Appelbaum AH, Kamba TT, Cohen AS, Qaisi WG, Amirkhan RH. Effectiveness and safety of image-directed biopsies: coaxial technique versus conventional fine-needle aspiration. South Med J. 2002;95(2):212–7.
Sheafor DH, Paulson EK, Kliewer MA, DeLong DM, Nelson RC. Comparison of sonographic and CT guidance techniques: does CT fluoroscopy decrease procedure time? AJR Am J Roentgenol. 2000;174(4):939–42.
Park SY, Park BK, Kim CK, Kwon GY. Ultrasound-guided core biopsy of small renal masses: diagnostic rate and limitations. J Vasc Interv Radiol. 2013;24(1):90–6.
Richard PO, Jewett MA, Bhatt JR, Kachura JR, Evans AJ, Zlotta AR, et al. Renal tumor biopsy for small renal masses: a single-center 13-year experience. Eur Urol. 2015;68(6):1007–13.
Dutta R, Okhunov Z, Vernez SL, Kaler K, Gulati AT, Youssef RF, et al. Cost comparisons between different techniques of percutaneous renal biopsy for small renal masses. J Endourol. 2016;30(Suppl 1):S28–33.
Volpe A, Finelli A, Gill IS, Jewett MA, Martignoni G, Polascik TJ, et al. Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol. 2012;62(3):491–504.
Volpe A, Kachura JR, Geddie WR, Evans AJ, Gharajeh A, Saravanan A, Jewett MA. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol. 2007;178(2):379–86.
Yang CS, Choi E, Idrees MT, Chen S, Wu HH. Percutaneous biopsy of the renal mass: FNA or core needle biopsy? Cancer Cytopathol. 2017;125(6):407–15.
Mullins JK, Rodriguez R. Renal cell carcinoma seeding of a percutaneous biopsy tract. Can Urol Assoc J. 2013;7(3–4):E176–9.
Chang DT, Sur H, Lozinskiy M, Wallace DM. Needle tract seeding following percutaneous biopsy of renal cell carcinoma. Korean J Urol. 2015;56(9):666–9.
Herts BR. Imaging guided biopsies of renal masses. Curr Opin Urol. 2000;10(2):105–9.
Patel HD, Johnson MH, Pierorazio PM, Sozio SM, Sharma R, Iyoha E, et al. Diagnostic accuracy and risks of biopsy in the diagnosis of a renal mass suspicious for localized renal cell carcinoma: systematic review of the literature. J Urol. 2016;195(5):1340–7.
Lees JS, McQuarrie EP, Mordi N, Geddes CC, Fox JG, Mackinnon B. Risk factors for bleeding complications after nephrologist-performed native renal biopsy. Clin Kidney J. 2017;10(4):573–7.
Okhunov Z, Moreira DM, Del Junco M, Abedi G, Lobko II, Kaler KS, et al. Predictors of complications after percutaneous image-guided renal cryoablation for T1a renal cortical neoplasms. J Endourol. 2017;31(1):7–13.
Wang W, Yu L, Wang Y, Zhang Q, Chi C, Zhan P, Xu C. Radial EBUS versus CT-guided needle biopsy for evaluation of solitary pulmonary nodules. Oncotarget. 2018;9(19):15122–31.
Papini E, Pacella CM, Hegedus L. Diagnosis of endocrine disease: thyroid ultrasound (US) and US-assisted procedures: from the shadows into an array of applications. Eur J Endocrinol. 2014;170(4):R133–46.
Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR Jr, et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol. 2007;178(1):41–6.
Lesage K, Joniau S, Fransis K, Van Poppel H. Comparison between open partial and radical nephrectomy for renal tumours: perioperative outcome and health-related quality of life. Eur Urol. 2007;51(3):614–20.
Campbell SC, Novick AC, Herts B, Fischler DF, Meyer J, Levin HS, et al. Prospective evaluation of fine needle aspiration of small, solid renal masses: accuracy and morbidity. Urology. 1997;50(1):25–9.
Burruni R, Lhermitte B, Cerantola Y, Tawadros T, Meuwly JY, Berthold D, et al. The role of renal biopsy in small renal masses. Can Urol Assoc J. 2016;10(1–2):E28–33.
Schmidbauer J, Remzi M, Memarsadeghi M, Haitel A, Klingler HC, Katzenbeisser D, et al. Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur Urol. 2008;53(5):1003–11.
Lebret T, et al. Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol. 2007;178(4 Pt 1):1184–8; discussion 1188.
Ficarra V, et al. Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours. Pathology. 2011;43(2):149–55.
Prince J, Bultman E, Hinshaw L, Drewry A, Blute M, Best S, et al. Patient and tumor characteristics can predict nondiagnostic renal mass biopsy findings. J Urol. 2015;193(6):1899–904.
Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee FT Jr, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why? Radiographics. 2014;34(5):1344–62.
Kelly EF, Leveillee RJ. Image guided radiofrequency ablation for small renal masses. Int J Surg. 2016;36(Pt C):525–32.
Klapperich ME, Abel EJ, Ziemlewicz TJ, Best S, Lubner MG, Nakada SY, et al. Effect of tumor complexity and technique on efficacy and complications after percutaneous microwave ablation of stage T1a renal cell carcinoma: a single-center, retrospective study. Radiology. 2017;284(1):272–80.
Zondervan PJ, Buijs M, de la Rosette JJ, van Delden O, van Lienden K, Laguna MP. Cryoablation of small kidney tumors. Int J Surg. 2016;36(Pt C):533–40.
Thompson RH, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol. 2015;67(2):252–9.
Katsanos K, Mailli L, Krokidis M, McGrath A, Sabharwal T, Adam A. Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours. Cardiovasc Intervent Radiol. 2014;37(2):427–37.
Chyhrai A, Sanjmyatav J, Gajda M, Reichelt O, Wunderlich H, Steiner T, et al. Multi-colour FISH on preoperative renal tumour biopsies to confirm the diagnosis of uncertain renal masses. World J Urol. 2010;28(3):269–74.
Halverson SJ, Kunju LP, Bhalla R, Gadzinski AJ, Alderman M, Miller DC, et al. Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology. J Urol. 2013;189(2):441–6.
Harisinghani MG, Maher MM, Gervais DA, McGovern F, Hahn P, Jhaveri K, et al. Incidence of malignancy in complex cystic renal masses (Bosniak category III): should imaging-guided biopsy precede surgery? AJR Am J Roentgenol. 2003;180(3):755–8.
Londono DC, Wuerstle MC, Thomas AA, Salazar LE, Hsu JW, Danial T, et al. Accuracy and implications of percutaneous renal biopsy in the management of renal masses. Perm J. 2013;17(3):4–7.
Menogue SR, O’Brien BA, Brown AL, Cohen RJ. Percutaneous core biopsy of small renal mass lesions: a diagnostic tool to better stratify patients for surgical intervention. BJU Int. 2013;111(4 Pt B):E146–51.
Millet I, Curros F, Serre I, Taourel P, Thuret R. Can renal biopsy accurately predict histological subtype and Fuhrman grade of renal cell carcinoma? J Urol. 2012;188(5):1690–4.
Reichelt O, Gajda M, Chyhrai A, Wunderlich H, Junker K, Schubert J. Ultrasound-guided biopsy of homogenous solid renal masses. Eur Urol. 2007;52(5):1421–6.
Salem S, Ponsky LE, Abouassaly R, Cherullo EE, Isariyawongse JP, Maclennan GT, et al. Image-guided biopsy of small renal masses in the era of ablative therapies. Int J Urol. 2013;20(6):580–4.
Shannon BA, Cohen RJ, de Bruto H, Davies RJ. The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses. J Urol. 2008;180(4):1257–61; discussion 61.
Sofikerim M, Tatlisen A, Canoz O, Tokat F, Demirtas A, Mavili E. What is the role of percutaneous needle core biopsy in diagnosis of renal masses? Urology. 2010;76(3):614–8.
Vasudevan A, Davies RJ, Shannon BA, Cohen RJ. Incidental renal tumours: the frequency of benign lesions and the role of preoperative core biopsy. BJU Int. 2006;97(5):946–9.
Wang R, Wolf JS Jr, Wood DP Jr, Higgins EJ, Hafez KS. Accuracy of percutaneous core biopsy in management of small renal masses. Urology. 2009;73(3):586–90; discussion 90–1.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Slongo, J., McDonald, M.W., Parikh, N., Sexton, W.J., Spiess, P.E., Mouraviev, V. (2020). Renal Mass Biopsy: An Evolution and Current Status. In: Leveillee, R., Jorda, M. (eds) Renal Mass Biopsy. Springer, Cham. https://doi.org/10.1007/978-3-030-36036-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-36036-8_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-36035-1
Online ISBN: 978-3-030-36036-8
eBook Packages: MedicineMedicine (R0)